Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Hall

Showing results (81-90 of 225) with videos related to

Pageof 23
Sort By:
BMJ Open|May 29, 2020
Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidanceShaista Hafeez, Emma Patel, Amanda Webster, et al.
Technical Innovations & Patient Support in Radiation Oncology|February 26, 2020
Linking CHHiP prostate cancer RCT with GP records: A study proposal to investigate the effect of co-morbidities and medications on long-term symptoms and radiotherapy-related toxicityAgnieszka Lemanska, Rachel C Byford, Ana Correa, et al.
Ebiomedicine|January 28, 2023
Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionationAnna Wilkins, Barry Gusterson, Holly Tovey, et al.
Trials|July 10, 2020
The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trialRebecca Lewis, Rachel Todd, Michelle Newton, et al.
British Journal of Cancer|January 27, 2017
The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)Ananya Choudhury, Catharine M West, Nuria Porta, et al.
Research Square|September 18, 2023
The canonical HPA axis facilitates and maintains light adaptive behaviorHan Lee, Soaleha Shams, Viet Ha Dang Thi, et al.
The Journal of Urology|February 7, 2025
Letter: Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 AmendmentRanil Johann Boaz, Wei Shen Tan, Paul Gravestock, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2023
Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic reviewZsuzsanna Iyizoba-Ebozue, Robin Prestwich, Sarah Brown, et al.
Australian Health Review : a Publication of the Australian Hospital Association|January 27, 2025
The impact of COVID-19 on public and private emergency departments in Queensland, AustraliaAmy L Sweeny, Emma Hall, Anthony Padowitz, et al.
Emergency Medicine Australasia : EMA|June 4, 2026
Identifying Symptom Clusters Predictive of Acute Myocardial Infarction for Aboriginal and Torres Strait Islander and Non-Indigenous AustraliansJaimi Greenslade, William Parsonage, Laura Stephensen, et al.
Pageof 23

Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
BMJ Open|May 29, 2020
Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidanceShaista Hafeez, Emma Patel, Amanda Webster, et al.
Technical Innovations & Patient Support in Radiation Oncology|February 26, 2020
Linking CHHiP prostate cancer RCT with GP records: A study proposal to investigate the effect of co-morbidities and medications on long-term symptoms and radiotherapy-related toxicityAgnieszka Lemanska, Rachel C Byford, Ana Correa, et al.
Ebiomedicine|January 28, 2023
Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionationAnna Wilkins, Barry Gusterson, Holly Tovey, et al.
Trials|July 10, 2020
The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trialRebecca Lewis, Rachel Todd, Michelle Newton, et al.
British Journal of Cancer|January 27, 2017
The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)Ananya Choudhury, Catharine M West, Nuria Porta, et al.
Research Square|September 18, 2023
The canonical HPA axis facilitates and maintains light adaptive behaviorHan Lee, Soaleha Shams, Viet Ha Dang Thi, et al.
The Journal of Urology|February 7, 2025
Letter: Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 AmendmentRanil Johann Boaz, Wei Shen Tan, Paul Gravestock, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2023
Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic reviewZsuzsanna Iyizoba-Ebozue, Robin Prestwich, Sarah Brown, et al.
Australian Health Review : a Publication of the Australian Hospital Association|January 27, 2025
The impact of COVID-19 on public and private emergency departments in Queensland, AustraliaAmy L Sweeny, Emma Hall, Anthony Padowitz, et al.
Emergency Medicine Australasia : EMA|June 4, 2026
Identifying Symptom Clusters Predictive of Acute Myocardial Infarction for Aboriginal and Torres Strait Islander and Non-Indigenous AustraliansJaimi Greenslade, William Parsonage, Laura Stephensen, et al.
Pageof 23